Machine Learning / AI in Drug Discovery

Slides:



Advertisements
Similar presentations
SOMA2 – Drug Design Environment. Drug design environment – SOMA2 The SOMA2 project Tekes (National Technology Agency of Finland) DRUG2000 program.
Advertisements

1 Real World Chemistry Virtual discovery for the real world Joe Mernagh 19 May 2005.
T HE V ALUE OF E NTERPRISE S EARCH Robert Gill & Pieter-Jan De Boeck.
Review of AI from Chapter 3. Journal May 13  What advantages and disadvantages do you see with using Expert Systems in real world applications like business,
Managing Knowledge in the Digital Firm (II) Soetam Rizky.
Chapter 12 Sections Q1-Q4: Business Intelligence Chapter 13 Sections Q2-Q4: Knowledge Mgmt Chapter 14 All Sections: Database Marketing Chapter 15 Sections.
PhysChem Forum, 29 Nov 2006, Newhouse 1 Memories and the future: From experimental to in silico physical chemistry Han van de Waterbeemd AstraZeneca, DMPK.
CHAPTER 4 DECISION SUPPORT AND ARTIFICIAL INTELLIGENCE Brainpower for Your Business.
Prof. Carolina Ruiz Computer Science Department Bioinformatics and Computational Biology Program WPI WELCOME TO BCB4003/CS4803 BCB503/CS583 BIOLOGICAL.
DSS: Decision Support Systems and AI: Artificial Intelligence
DSS: Decision Support Systems and AI: Artificial Intelligence
McGraw-Hill/Irwin ©2005 The McGraw-Hill Companies, All rights reserved ©2005 The McGraw-Hill Companies, All rights reserved McGraw-Hill/Irwin.
Executive Dashboard Systems Secure CITI Adam Zagorecki April 30, 2004.
Drug discovery and development
Mining Large Data at SDSC Natasha Balac, Ph.D.. A Deluge of Data Astronomy Life Sciences Modeling and Simulation Data Management and Mining Geosciences.
ACS San Francisco, Spring 2000 Case Studies: Electronic Laboratory Notebooks Keith T Taylor & Phil McHale MDL Information Systems Inc.
1 Data Mining Books: 1.Data Mining, 1996 Pieter Adriaans and Dolf Zantinge Addison-Wesley 2.Discovering Data Mining, 1997 From Concept to Implementation.
Introduction GAM 376 Robin Burke Winter Outline Introductions Syllabus.
© 2003 Prentice Hall, Inc.1-1 Chapter 1 Information Systems: The Big Picture Information Systems Today Leonard Jessup and Joseph Valacich.
PUTTING MANAGED FILE TRANSFER IN PERSPECTIVE May 2015 Derek E. Brink, CISSP, Vice President and Research Fellow IT Security and IT GRC.
REU 2004 Computer Science and Engineering Department The University of Texas at Arlington Research Experiences for Undergraduates in Distributed Rational.
Dendral: A Case Study Lecture 25.
PowerPoint Presentation by Charlie Cook Copyright © 2004 South-Western. All rights reserved. Chapter 5 Business Intelligence and and Knowledge Management.
Delivering Differentiation and Competitive Advantage in the New Data Center World Michael Beach Microsoft Global High Tech Summit Thursday October 25,
Chapter 9 The People in Information Systems. Learning Objectives Upon successful completion of this chapter, you will be able to: Describe each of the.
Axis AI Solves Challenges of Complex Data Extraction and Document Classification through Advanced Natural Language Processing and Machine Learning MICROSOFT.
The Three E’s of Big Data and What DB People can do About Them UC BERKELEY Michael Franklin – UC Berkeley Beckman Database Get Together October 14, 2013.
Dr. Andrew Jones Clinical Director. Managing Alert Fatigue ePrescribing Masterclass WebEx 3rd February 2016, 1-2pm.
MDL Information Systems, Inc. Powering the Process of Invention Donna del Rey Director, Business Planning
Molecular Modeling in Drug Discovery: an Overview
Paul Ormonde-James 2014 CYBERTREKING.COM By Paul Ormonde-James January 2014 The future is closed than you think. COM.
Decision Support and Business Intelligence Systems (9 th Ed., Prentice Hall) Chapter 12: Artificial Intelligence and Expert Systems.
Page 1 Computer-aided Drug Design —Profacgen. Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will.
Introducing Precictive Analytics
Digital Asset Management & Storage Program Program Summary
WHAT IS KENSHO? KENSHO IS A DATA ANALYTICS AND MACHINE INTELLIGENCE COMPANY Kensho deploys pioneering real-time statistical computing, scalable.
It’s Time for Cognitive Computing
Service Assurance in the Age of Virtualization
Organizations Are Embracing New Opportunities
Primal and Microsoft Azure Deliver Personalized Content, Intelligence, and Analytics That Match Your Content to the Interests of Your Audience MICROSOFT.
DSS: Decision Support Systems and AI: Artificial Intelligence
The 2007 Winter Conference on Business Intelligence
Through the Eyes of Data
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
ADME/Tox PredictionTox Prediction. The characterization of Absorption, Distribution, Metabolism, and Excretion (also known as ADME) and Toxicity are essential.
Culture 1.
Accelerating intelligent automation for competitive advantage
Enterprise Productivity Services
Microsoft Azure Platform Powers New Elements Constellation Software Suite to Deliver Invaluable Insights From Your Data for Marketing and Sales MICROSOFT.
BANKING INFORMATION SYSTEMS
Consulting Services for IoT
BUREAU VERITAS COMMODITIES
Real-time BioPharmaceutical R&D
Digital Transformation Asia 2018 – CALL FOR SPEAKERS
AI & ML Lessons Learnt & real-world challenges Avishkar Misra PhD
Virtual Screening.
Term Definition Examples Data Science Statistics with large data sets
DeFacto Planning on the Powerful Microsoft Azure Platform Puts the Power of Intelligent and Timely Planning at Any Business Manager’s Fingertips Partner.
Replace with Application Image
Big Data Young Lee BUS 550.
Quasardb Is a Fast, Reliable, and Highly Scalable Application Database, Built on Microsoft Azure and Designed Not to Buckle Under Demand MICROSOFT AZURE.
Industrializing AI.
Intelligent Process Automation in Audit
William Y. Chang Office of VP for Research and Innovation
CRITICAL CARE NURSES CHAPTER----QUALITY IN CRITICAL CARE.
Sachiko A. Kuwabara, PhD, MA
Recent trends of machine learning in healthcare
The Intelligent Enterprise and SAP Business One
What is UiPATH? For more details visit this link online-training.
Presentation transcript:

Machine Learning / AI in Drug Discovery Medicinal & Synthetic Chemistry Perspective Dr Ed Griffen Technical Director MedChemica

Machine Learning / AI in Drug Discovery Medicinal & Synthetic Chemistry Perspective TI LG LO Organization Scientist Data and Technology Ed Griffen 2018

ML in Chemistry Maturity > than any chemist & database = an experienced chemist with a large Pharma database = experienced chemist = graduate chemist Random – no effect

Synthesis route design ML in Chemistry Maturity $ Value Virtual Screening Synthesis route design Potency Optimization ADME Optimization Tox Alerts Polymorph Prediction LG LO Ed Griffen 2018

Open source and cloud driving the revolution Data and Technology Open source and cloud driving the revolution Cloud zero barrier to entry instantly scalable massive user base Data DB technologies ubiquitous Public data growing Large volumes of well curated data essential Machine Learning Libraries ubiquitous Large user base Ed Griffen 2018

Only Big Pharma have enough data? Data and Technology Only Big Pharma have enough data? NLP – Natural Language Processing BenevolentAI Ed Griffen 2018

Synthesis route design ML in Chemistry Maturity Virtual Screening ADME Optimization Synthesis route design Polymorph Prediction Tox Alerts Potency Optimization $ Value Ed Griffen 2018

Better Project decisions Increased Medicinal Chemistry learning ADME Optimization Making a real textbook of Medicinal Chemistry MMPA Combine and Extract Rules AstraZeneca, Roche and Genentech ADMET data >437000 rules Better Project decisions Increased Medicinal Chemistry learning Learning Medicinal Chemistry Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) Rules from Cross-Company Matched Molecular Pairs Analysis (MMPA). Kramer, Robb, Ting, Zheng, Griffen, et al. J. Med. Chem. 2017 http://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00935

Synthesis Route Design Automated Retrosynthetic analysis comes of age

Help the HiPPOs – or they’ll crush you Scientists Help the HiPPOs – or they’ll crush you “Companies often make most of their important decisions by relying on “HiPPO”—the highest-paid person’s opinion.”1 Chemistry HiPPs: experts in pattern recognition judged on their ability to make the best decisions with partial data highly trained time poor delivery focused gatekeepers to the adoption of new approaches McAfee & Brynjolfsson “Big Data: The Management Revolution”, Harvard Business Review October 2012 Ed Griffen 2018

Is ML in chemistry mature enough yet? Scientists Is ML in chemistry mature enough yet? Replace the chemist with automation? Propose Compounds Advantages Speed Lack of bias Cost per compound Scalability No explanations needed! Risks Fragile models Unclear where they fail Un-auditable MedChemica Prediction & error prediction Sort &Filter Like a blind man in a Tesla on Auto pilot… what could go wrong [Al Pacino as Frank Slade in ‘Scent of a woman”] [do you want your project manager to be like Chris O’Donnell?] Lee Cronin Nature (559) , 377 – 381 (2018)

Scientists Christian Tyrchan AZ Gothenberg Ed Griffen 2018

Chemists enhanced by Computational Intelligence Scientists Chemists enhanced by Computational Intelligence Advantages Integrating experience Critical analysis Stopping ‘stupid’ errors Propose Compounds MedChemica context Prediction & error prediction Sort &Filter Risks Complexity Slower: humans in decision loop Critical: Person – machine interface Lee Cronin Nature (559) , 377 – 381 (2018)

Scientists Ed Griffen 2018

Organization Machine Learning challenges (powerful) cognitive workers Technologies cross previous organizational boundaries Options to address internal organizational resistance to change: Skunkworks Acquisitions Ed Griffen 2018

Machine Learning / AI in Drug Discovery Medicinal & Synthetic Chemistry Perspective Summary AI is delivering on the back of massive data sets, turn-key high performance computing ubiquitous machine learning libraries choose: build it or buy it Challenges Knowledge workers are more challenged by AI Integration or automation Organizational change Ed Griffen 2018